Multicenter automatic defibrillator implantation trial: Reduce inappropriate therapy (MADIT-RIT): Background, rationale, and clinical protocol

Annals of Noninvasive Electrocardiology

Volumn 17, Issue 3, 2012, Pages 176-185

  Schuger, Claudio ^a   Daubert, James P ^b   Brown, Mary W ^c   Cannom, David ^d   Estes III, N A Mark ^e   Hall, W Jackson ^c   Kayser, Torsten ^f   Klein, Helmut ^c   Olshansky, Brian ^g   Power, Keith A ^h   Wilber, David ⁱ   Zareba, Wojciech ^c   Moss, Arthur J ^c  

^a HENRY FORD HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d GOOD SAMARITAN HOSPITAL   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f Boston Scientific Corporation   (Belgium)

^g UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^h BOSTON SCIENTIFIC CORPORATION   (United States)

ⁱ LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

defibrillation therapy; implantable defibrillators; sudden cardiac death

Indexed keywords

ARTICLE; BRADYCARDIA; CARDIOVASCULAR MORTALITY; CLINICAL PROTOCOL; DEFIBRILLATOR; ELECTROGRAPHY; FOLLOW UP; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CANADA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; EQUIPMENT SAFETY; EUROPE; FEMALE; HUMANS; ISRAEL; JAPAN; MALE; MEDICAL ERRORS; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME; UNITED STATES;

EID: 84864184436     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2012.00531.x     Document Type: Article

References (28)

1. Moss AJ, Hall WJ, Cannom DS, et al,. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996; 335: 1933-1940. (Pubitemid 26428217)
2. Moss AJ, Zareba W, Hall WJ, et al,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med. 2002; 346: 877-883. (Pubitemid 34984635)
3. Bardy GH, Lee KL, Mark DB, et al,. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352: 225-237. (Pubitemid 40110811)
4. Poole JE, Johnson GW, Hellkamp AS, et al,. Prognosticimportance of defibrillator shocks in patients with heart failure. N EnglJ Med 2008; 359: 1009-1017.
5. Daubert JP, Zareba W, Cannom DS, et al,. MADIT II Investigators. Inappropriate implantablecardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365. (Pubitemid 351443082)
6. Ellenbogen KA, Levine JH, Berger RD, et al,. Defibrillatorsin Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006; 113: 776-782.
7. Wilkoff BL, Williamson BD, Stern RS, et al,. PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantablecardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52: 541-550.
8. Grimm W, Flores BF, Marchlinski FE,. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992; 15: 1667-1673.
9. Schmitt C, Montero M, Melichercik J,. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. Pacing Clin Electrophysiol 1994; 17: 295-302. (Pubitemid 24092111)
10. Theuns DA, Klootwijk AP, Simoons ML, et al,. Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. Am J Cardiol 2005; 95: 271-274. (Pubitemid 40092100)
11. Schron EB, Exner DV, Yao Q, et al,. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594. (Pubitemid 34123433)
12. Namerow PB, Firth B, Heywood GM, et al,. Quality of life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. PACE 1999; 22: 1305-1313. (Pubitemid 29485030)
13. Irvine J, Dorian P, Baker BM, et al,. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002; 144: 282-289. (Pubitemid 34879652)
14. Klein RC, Raitt MH, Wilkoff BL, et al,. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 2003; 14: 940-948. (Pubitemid 37115157)
15. Van Rees JB, Borleffs CJW, De Bie MK, et al,. Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57 556-562
16. Kuhlkamp V, Dornberger V, Mewis C, et al,. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999; 10: 905-915. (Pubitemid 29297709)
17. Deisenhofer I, Kolb C, Ndrepepa G, et al,. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001; 12: 134-142. (Pubitemid 32171500)
18. Theuns DA, Klootwijk AP, Goedhart DM, et al,. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am College Cardiol 2004; 44: 2362-2367. (Pubitemid 39647611)
19. Olshansky B, Day JD, Moore S, et al,. Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter- defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study. Circulation 2007; 115: 9-16. (Pubitemid 46058606)
20. Friedman PA, McClelland RL, Bamlet WR, et al,. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study. Circulation 2006; 113: 2871-2879. (Pubitemid 44297227)
21. Rienstra M, Smit MD, Nieuwland W, et al,. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardiovertr defibrillator. Am Heart J 2007; 143: 120-126. (Pubitemid 44880874)
22. Dewland TA, Pellegrini CN, Wang Y, et al,. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry. J Am Coll Cardiol 2011; 58: 1007-1013
23. Spragg DD, Berger R,. How to avoid inappropriate shocks. Heart Rhythm 2008; 5: 762-765.
24. Lawless JF,. Statistical Models and Methods for Lifetime Data (Chapter 9), 2nd edition, 2003. Hoboken, NJ, John Wiley.
25. Muhlbaier LH,. HIPAA Training Handbook for Researchers, Opus Communications, Inc. Marblehead, MA, 2002.
26. Kim SG, Fogoros RN, Furman S, et al,. Standardized reporting of ICD patient outcome: The report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993. Pacing Clin Electrophysiol 193; 16: 1358-1362. (Pubitemid 23209205)
27. Epstein AE, Carlson MD, Fogoros RN, et al,. Classification of death in antiarrhythmia trials. J Am Coll Cardiol 1996; 27: 433-442. (Pubitemid 26046621)
28. Hinkle LE, Jr., Thaler HT,. Clinical classification of cardiac deaths. Circulation 1982; 65: 457-464. (Pubitemid 12168347)